JP2008518914A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518914A5
JP2008518914A5 JP2007539060A JP2007539060A JP2008518914A5 JP 2008518914 A5 JP2008518914 A5 JP 2008518914A5 JP 2007539060 A JP2007539060 A JP 2007539060A JP 2007539060 A JP2007539060 A JP 2007539060A JP 2008518914 A5 JP2008518914 A5 JP 2008518914A5
Authority
JP
Japan
Prior art keywords
magnesium
analgesic
antipyretic
calcium carbonate
alkaline substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007539060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518914A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038507 external-priority patent/WO2006049978A1/en
Publication of JP2008518914A publication Critical patent/JP2008518914A/ja
Publication of JP2008518914A5 publication Critical patent/JP2008518914A5/ja
Pending legal-status Critical Current

Links

JP2007539060A 2004-10-28 2005-10-26 アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物 Pending JP2008518914A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62281204P 2004-10-28 2004-10-28
PCT/US2005/038507 WO2006049978A1 (en) 2004-10-28 2005-10-26 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (2)

Publication Number Publication Date
JP2008518914A JP2008518914A (ja) 2008-06-05
JP2008518914A5 true JP2008518914A5 (cg-RX-API-DMAC7.html) 2008-12-04

Family

ID=35744599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007539060A Pending JP2008518914A (ja) 2004-10-28 2005-10-26 アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物

Country Status (17)

Country Link
US (1) US20070298096A1 (cg-RX-API-DMAC7.html)
EP (1) EP1807068B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008518914A (cg-RX-API-DMAC7.html)
CN (1) CN101048155A (cg-RX-API-DMAC7.html)
AR (1) AR051145A1 (cg-RX-API-DMAC7.html)
AT (1) ATE460930T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005302618B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0520000A2 (cg-RX-API-DMAC7.html)
CA (1) CA2583517C (cg-RX-API-DMAC7.html)
DE (1) DE602005020048D1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005121A (cg-RX-API-DMAC7.html)
NO (1) NO20072255L (cg-RX-API-DMAC7.html)
PE (1) PE20061125A1 (cg-RX-API-DMAC7.html)
PL (1) PL1807068T3 (cg-RX-API-DMAC7.html)
PT (1) PT1807068E (cg-RX-API-DMAC7.html)
RU (1) RU2398571C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006049978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
CN100417385C (zh) * 2006-09-26 2008-09-10 林星 一种用于治疗外伤的外用制剂
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101596163B (zh) * 2008-06-06 2012-06-27 康美保宁(四川)制药有限公司 阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
CN102861040B (zh) * 2012-08-02 2014-04-23 广东环球制药有限公司 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) * 2012-09-06 2013-03-06 广东九明制药有限公司 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) * 2017-12-15 2018-11-13 Lisa Josette Myslinski Multisymptom migraine combination medication
CN110711197B (zh) * 2018-07-12 2023-11-24 北京恒润泰生医药科技有限公司 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) * 2018-08-15 2018-11-23 康美保宁(四川)制药有限公司 一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2101014C1 (ru) * 1995-09-07 1998-01-10 Акционерное общество "Курский комбинат лекарственных средств" Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
US20040147606A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
JP4553552B2 (ja) * 2003-01-08 2010-09-29 日東薬品工業株式会社 生体リズム応用キット

Similar Documents

Publication Publication Date Title
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
WO2005079752A3 (en) Controlled release pharmaceutical compositions with improved bioavailability
HRP20191892T1 (hr) Sublingvalna formulacija riluzola
NO20082744L (no) Oral farmasoytisk doseform omfattende som aktive ingredienser en proton pumpeinhibitor sammen med acetylsalicylsyre
JP5810819B2 (ja) 積層錠
EA200602294A1 (ru) Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества
JP2005068010A5 (cg-RX-API-DMAC7.html)
ES2644373T3 (es) Comprimido efervescente que contiene elevado nivel de aspirina
JP7348703B2 (ja) メロキシカム含有造粒物
RS59667B1 (sr) Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
AR036085A1 (es) Formas de dosificacion y procedimiento para su fabricacion
Patil et al. Natural gum as mucoadhesive controlled release carriers: evaluation of Cefpodoxime Proxetil by D-Optimal design technique
JP2008515980A5 (cg-RX-API-DMAC7.html)
RU2007119641A (ru) Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции
JP2006232675A (ja) 複合型口腔内溶解用固形製剤
JP2009514786A5 (cg-RX-API-DMAC7.html)
WO2013123487A1 (en) Alkalized acacia gum adhesive for oral adhering discs
WO2004096125A3 (en) Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
WO2001022943A8 (en) A slow release pharmaceutical composition comprising a magnesium oxychloride cement
JP2013043854A (ja) 生薬含有製剤
ES2770141T3 (es) Comprimido multicapa para administración de magnesio
JP6822034B2 (ja) 安定性及び速効性の高いイブプロフェン含有固形製剤
US9422701B2 (en) Toilet water splash inhibiting device
JP2019116506A (ja) 固形製剤
WO2006023295A3 (en) Pharmaceutical compositions comprising effervescent agents and fenofibrate